CLRB
Cellectar Biosciences Inc
NASDAQ: CLRB · HEALTHCARE · BIOTECHNOLOGY
$2.56
-0.02% today
Updated 2026-04-29
Market cap
$11.70M
P/E ratio
—
P/S ratio
348.47x
EPS (TTM)
$-8.35
Dividend yield
—
52W range
$2 – $21
Volume
0.0M
Cellectar Biosciences Inc (CLRB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12584.00 | — | $125968.00 | $96314.00 | $33334.00 | $-11000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | -100.0% | — | -23.5% | -65.4% | -133.0% | +100.0% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $362502.00 | $356665.00 | $1.55M | $82265.00 | $189360.00 | $207929.00 | $227636.00 | $238867.00 | $192375.00 | $291653.00 | $213597.00 |
| Gross profit | $12584.00 | — | $125968.00 | $96314.00 | $33334.00 | $-11000.00 | $0.00 | $0.00 | $0.00 | $-362502.00 | $-356665.00 | $-1.55M | $-82265.00 | $-189360.00 | $-207929.00 | $-227636.00 | $-238867.00 | $-192375.00 | $-291653.00 | $-213597.00 |
| Gross margin | 100.0% | — | 100.0% | 100.0% | 100.0% | 100.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $6.44M | $17.43M | $14.53M | $8.08M | $3.00M | $3.60M | $5.12M | $6.86M | $5.96M | $5.16M | $4.75M | $9.47M | $6.84M | $9.00M | $10.14M | $17.59M | $19.22M | $27.27M | $26.14M | $11.50M |
| SG&A | $2.49M | $2.87M | $2.19M | $2.18M | $2.49M | $2.69M | $3.63M | $4.44M | $3.70M | $3.40M | $4.70M | $4.14M | $4.82M | $5.18M | $5.15M | $6.54M | $9.59M | $11.69M | $25.64M | $11.48M |
| Operating income | $-8.93M | $-20.29M | $-16.59M | $-10.23M | $-5.45M | $-7.04M | $-8.75M | $-12.40M | $-9.89M | $-8.76M | $-9.45M | $-13.60M | $-13.33M | $-14.18M | $-15.29M | $-24.13M | $-28.81M | $-38.96M | $-51.78M | $-22.98M |
| Operating margin | -70961.6% | — | -13170.8% | -10620.6% | -16351.7% | 63979.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-8.28M | $-19.54M | $-16.57M | $-10.13M | $-12.96M | $-6.33M | $-8.29M | $-10.88M | $-9.30M | $-11.61M | $-9.09M | $-12.05M | $-13.16M | $-13.90M | $-14.89M | $-23.98M | $-28.67M | $-38.77M | $-51.49M | $-22.77M |
| EBITDA margin | -65770.3% | — | -13157.4% | -10521.7% | -38876.2% | 57519.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-8.29M | $-19.56M | $-16.59M | $-10.17M | $-12.99M | $-6.91M | $-8.79M | $-11.30M | $-9.67M | $-11.98M | $-9.45M | $-13.60M | $-13.24M | $-14.09M | $-15.09M | $-24.13M | $-28.81M | $-38.96M | $-51.78M | $-22.98M |
| Interest expense | $0.00 | $0.00 | $130611.00 | $1013.00 | $2421.00 | $430023.00 | $9335.00 | $9348.00 | $446314.00 | $841.00 | $7897.00 | $16605.00 | $29687.00 | $42712.00 | $10897.00 | $2284.00 | $300954.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-8.29M | $-19.56M | $-16.45M | $-22.27M | $2.10M | $-7.44M | $-8.80M | $-10.78M | $-8.11M | $-5.50M | $-6.18M | $-13.56M | $-13.24M | $-14.09M | $-15.09M | $-23.97M | $-28.60M | $-42.77M | $-44.58M | $-21.79M |
| Net income growth (YoY) | — | -136.0% | +15.9% | -35.4% | +109.4% | -454.8% | -18.3% | -22.6% | +24.8% | +32.2% | -12.5% | -119.4% | +2.4% | -6.4% | -7.1% | -58.8% | -19.3% | -49.5% | -4.2% | +51.1% |
| Profit margin | -65846.0% | — | -13060.0% | -23125.7% | 6286.1% | 67594.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |